| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 24 hours |
| 被験者数 | 12 |
| 性別 | 男女 |
| 年齢 | 18-29 |
この研究の注釈：
In persons who had a panic attack induced by m-CPP intravenous administration, a single acute dose of 20g inositol failed to reduce the subsequent symptoms of panic relative to placebo treatment.
Double-blind, Controlled, Crossover Trial Of Inositol Versus Fluvoxamine For The Treatment Of Panic Disorder
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 2-4 週間 |
| 被験者数 | 20 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44, 45-64 |
この研究の注釈：
18g of inositol taken daily for one month in persons with panic disorder was associated with a significant reduction in panic attack symptoms (more potent than the reference drug of fluvoxamine) and anxiety symptoms (comparable in potency)
Double-blind, Placebo-controlled, Crossover Trial Of Inositol Treatment For Panic Disorder
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 2-4 週間 |
| 被験者数 | 21 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44 |
この研究の注釈：
12g of inositol daily for a period of 4 weeks is associated with reductions in symptoms of panic disorder and anxiety, particularly a reduction in agoraphobia.
